Mark A. Atkinson - Publications

Affiliations: 
University of Florida, Gainesville, Gainesville, FL, United States 
Area:
Immunology, Epidemiology

200 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Battaglia M, Ahmed S, Anderson MS, Atkinson MA, Becker D, Bingley PJ, Bosi E, Brusko TM, DiMeglio LA, Evans-Molina C, Gitelman SE, Greenbaum CJ, Gottlieb PA, Herold KC, Hessner MJ, et al. Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes. Diabetes Care. PMID 31753960 DOI: 10.2337/dc19-0880  0.4
2019 Kusmartseva I, Beery M, Hiller H, Padilla M, Selman S, Posgai A, Nick HS, Campbell-Thompson M, Schatz DA, Haller MJ, Wasserfall CH, Atkinson MA. Temporal Analysis of Amylase Expression in Control, Autoantibody Positive, and Type 1 Diabetes Pancreatic Tissues. Diabetes. PMID 31597639 DOI: 10.2337/db19-0554  0.4
2019 Russell JT, Roesch LFW, Ördberg M, Ilonen J, Atkinson MA, Schatz DA, Triplett EW, Ludvigsson J. Genetic risk for autoimmunity is associated with distinct changes in the human gut microbiome. Nature Communications. 10: 3621. PMID 31399563 DOI: 10.1038/s41467-019-11460-x  0.4
2019 Shapiro MR, Atkinson MA, Brusko TM. Pleiotropic roles of the insulin-like growth factor axis in type 1 diabetes. Current Opinion in Endocrinology, Diabetes, and Obesity. PMID 31145130 DOI: 10.1097/MED.0000000000000484  0.4
2019 Lewis JS, Stewart JM, Marshall GP, Carstens MR, Zhang Y, Dolgova NV, Xia C, Brusko TM, Wasserfall CH, Clare-Salzler MJ, Atkinson MA, Keselowsky BG. Dual-Sized Microparticle System for Generating Suppressive Dendritic Cells Prevents and Reverses Type 1 Diabetes in the Nonobese Diabetic Mouse Model. Acs Biomaterials Science & Engineering. 5: 2631-2646. PMID 31119191 DOI: 10.1021/acsbiomaterials.9b00332  0.4
2019 Haller MJ, Long SA, Blanchfield JL, Schatz DA, Skyler JS, Krischer JP, Bundy BN, Geyer SM, Warnock MV, Miller JL, Atkinson MA, Becker DJ, Baidal DA, DiMeglio LA, Gitelman SE, et al. Low-dose Anti-Thymocyte Globulin Preserves C-Peptide and Reduces A1c in New Onset Type 1 Diabetes: Two Year Clinical Trial Data. Diabetes. PMID 30967424 DOI: 10.2337/db19-0057  0.4
2019 Damond N, Engler S, Zanotelli VRT, Schapiro D, Wasserfall CH, Kusmartseva I, Nick HS, Thorel F, Herrera PL, Atkinson MA, Bodenmiller B. A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry. Cell Metabolism. PMID 30713109 DOI: 10.1016/j.cmet.2018.11.014  0.4
2019 Campbell-Thompson ML, Filipp SL, Grajo JR, Nambam B, Beegle R, Middlebrooks EH, Gurka MJ, Atkinson MA, Schatz DA, Haller MJ. Relative Pancreas Volume Is Reduced in First-Degree Relatives of Patients With Type 1 Diabetes. Diabetes Care. 42: 281-287. PMID 30552130 DOI: 10.2337/dc18-1512  0.4
2018 Tezza S, Ben Nasr M, D'Addio F, Vergani A, Usuelli V, Falzoni S, Bassi R, Dellepiane S, Fotino C, Rossi C, Maestroni A, Solini A, Corradi D, Giani E, Mameli C, ... ... Atkinson MA, et al. Islet-Derived eATP Fuels Autoreactive CD8 Cells and Facilitates the Onset of Type 1 Diabetes. Diabetes. PMID 30065030 DOI: 10.2337/db17-1227  0.4
2018 Haller MJ, Schatz DA, Skyler JS, Krischer JP, Bundy BN, Miller JL, Atkinson MA, Becker DJ, Baidal D, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Herold KC, Marks JB, et al. Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA in New-Onset Type 1 Diabetes. Diabetes Care. PMID 30012675 DOI: 10.2337/dc18-0494  0.4
2018 Greenbaum CJ, Speake C, Krischer J, Buckner J, Gottlieb PA, Schatz DA, Herold KC, Atkinson MA. Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes-The TrialNet Experience. Diabetes. PMID 29769238 DOI: 10.2337/db18-0065  0.4
2018 Perry DJ, Wasserfall CH, Oram RA, Williams MD, Posgai A, Muir AB, Haller MJ, Schatz DA, Wallet MA, Mathews CE, Atkinson MA, Brusko TM. Application of a Genetic Risk Score to Racially Diverse Type 1 Diabetes Populations Demonstrates the Need for Diversity in Risk-Modeling. Scientific Reports. 8: 4529. PMID 29540798 DOI: 10.1038/s41598-018-22574-5  0.4
2017 Kusmartseva I, Beery M, Philips T, Selman S, Jadhav P, Wasserfall C, Muller A, Pugliese A, Longmate JA, Schatz DA, Atkinson MA, Kaddis JS. Hospital time prior to death and pancreas histopathology: implications for future studies. Diabetologia. PMID 29128936 DOI: 10.1007/s00125-017-4494-x  0.4
2017 Kemppainen KM, Vehik K, Lynch KF, Larsson HE, Canepa RJ, Simell V, Koletzko S, Liu E, Simell OG, Toppari J, Ziegler AG, Rewers MJ, Lernmark Å, Hagopian WA, She JX, ... ... Atkinson MA, et al. Association Between Early-Life Antibiotic Use and the Risk of Islet or Celiac Disease Autoimmunity. Jama Pediatrics. PMID 29052687 DOI: 10.1001/jamapediatrics.2017.2905  0.4
2017 Chen J, Chernatynskaya AV, Li JW, Kimbrell MR, Cassidy RJ, Perry DJ, Muir AB, Atkinson MA, Brusko TM, Mathews CE. T cells display mitochondria hyperpolarization in human type 1 diabetes. Scientific Reports. 7: 10835. PMID 28883439 DOI: 10.1038/s41598-017-11056-9  0.4
2017 Newby BN, Brusko TM, Zou B, Atkinson MA, Clare-Salzler M, Mathews CE. Type 1 Interferons Potentiate Human CD8(+) T Cell Cytotoxicity Through a STAT4 and Granzyme B Dependent Pathway. Diabetes. PMID 28877912 DOI: 10.2337/db17-0106  0.4
2017 Wan H, Merriman C, Atkinson MA, Wasserfall CH, Mcgrail KM, Liang Y, Fu D, Dai H. Proteoliposome-based full-length ZnT8 self-antigen for type 1 diabetes diagnosis on a plasmonic platform. Proceedings of the National Academy of Sciences of the United States of America. PMID 28874568 DOI: 10.1073/pnas.1711169114  0.4
2017 Jacobsen LM, Haller MJ, Parish A, Gurka MJ, Levine SR, Wasserfall C, Campbell-Thompson M, Kaddis J, Pugliese A, Atkinson MA, Schatz DA. High Illicit Drug Abuse and Suicide in Organ Donors With Type 1 Diabetes. Diabetes Care. PMID 28679687 DOI: 10.2337/dc17-0996  0.4
2017 Marcial GE, Ford AL, Haller MJ, Gezan SA, Harrison NA, Cai D, Meyer JL, Perry DJ, Atkinson MA, Wasserfall CH, Garrett T, Gonzalez CF, Brusko TM, Dahl WJ, Lorca GL. Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults. Frontiers in Immunology. 8: 655. PMID 28659913 DOI: 10.3389/fimmu.2017.00655  0.4
2017 Seay HR, Putnam AL, Cserny J, Posgai AL, Rosenau EH, Wingard JR, Girard KF, Kraus M, Lares AP, Brown HL, Brown KS, Balavage KT, Peters LD, Bushdorf AN, Atkinson MA, et al. Expansion of Human Tregs from Cryopreserved Umbilical Cord Blood for GMP-Compliant Autologous Adoptive Cell Transfer Therapy. Molecular Therapy. Methods & Clinical Development. 4: 178-191. PMID 28345003 DOI: 10.1016/j.omtm.2016.12.003  0.4
2017 Posgai AL, Wasserfall CH, Kwon KC, Daniell H, Schatz DA, Atkinson MA. Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice. Scientific Reports. 7: 42372. PMID 28205558 DOI: 10.1038/srep42372  0.4
2017 Li X, Campbell-Thompson M, Wasserfall CH, McGrail K, Posgai A, Schultz AR, Brusko TM, Shuster J, Liang F, Muir A, Schatz D, Haller MJ, Atkinson MA. Serum Trypsinogen Levels in Type 1 Diabetes. Diabetes Care. PMID 28115475 DOI: 10.2337/dc16-1774  0.4
2016 Philips T, Kusmartseva I, Gerling IC, Campbell-Thompson M, Wasserfall C, Pugliese A, Longmate JA, Schatz DA, Atkinson MA, Kaddis JS. Factors That Influence the Quality of RNA From the Pancreas of Organ Donors. Pancreas. PMID 27984510 DOI: 10.1097/MPA.0000000000000717  0.4
2016 Seay HR, Yusko E, Rothweiler SJ, Zhang L, Posgai AL, Campbell-Thompson M, Vignali M, Emerson RO, Kaddis JS, Ko D, Nakayama M, Smith MJ, Cambier JC, Pugliese A, Atkinson MA, et al. Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes. Jci Insight. 1: e88242. PMID 27942583 DOI: 10.1172/jci.insight.88242  0.4
2016 Bonifacio E, Mathieu C, Nepom GT, Ziegler AG, Anhalt H, Haller MJ, Harrison LC, Hebrok M, Kushner JA, Norris JM, Peakman M, Powers AC, Todd JA, Atkinson MA. Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity. Diabetologia. PMID 27785529 DOI: 10.1007/s00125-016-4144-8  0.32
2016 Haller MJ, Gitelman SE, Gottlieb PA, Michels AW, Perry DJ, Schultz AR, Hulme MA, Shuster JJ, Zou B, Wasserfall CH, Posgai A, Mathews CE, Brusko TM, Atkinson MA, Schatz DA. Anti-Thymocyte Globulin + G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders with Established Type 1 Diabetes. Diabetes. PMID 27669730 DOI: 10.2337/db16-0823  0.4
2016 Jacobsen LM, Atkinson MA, Campbell-Thompson M, Schatz DA. Presumptive Type 1 Diabetes With Comorbidities and Rapid Progression Despite Numerous Insulin-Positive Islets. Diabetes Care. 39: 1292-4. PMID 27330131 DOI: 10.2337/dc16-0737  0.4
2016 Buschard K, Bracey AW, McElroy DL, Magis AT, Osterbye T, Atkinson MA, Bailey KM, Posgai AL, Ostrov DA. Sulfatide Preserves Insulin Crystals Not by Being Integrated in the Lattice but by Stabilizing Their Surface. Journal of Diabetes Research. 2016: 6179635. PMID 26981544 DOI: 10.1155/2016/6179635  0.4
2016 Campbell-Thompson ML, Schatz DA, Kaddis JS, Atkinson MA. Pancreatic duct hyperplasia/dysplasia in type 1 diabetes and pancreatic weight in individuals with and without diabetes. Reply to Kobayashi T, Aida K, Fukui T et al [letter] and Saisho Y [letter]. Diabetologia. 59: 870-2. PMID 26861059 DOI: 10.1007/s00125-016-3889-4  0.4
2016 Campbell-Thompson ML, Schatz DA, Kaddis JS, Atkinson MA. Pancreatic duct hyperplasia/dysplasia in type 1 diabetes and pancreatic weight in individuals with and without diabetes. Reply to Kobayashi T, Aida K, Fukui T et al [letter] and Saisho Y [letter] Diabetologia. 59: 870-872. DOI: 10.1007/s00125-016-3889-4  0.4
2015 Gill RG, Pagni PP, Kufper T, Wasserfall CH, Deng S, Posgai A, Manenkova Y, Hani AB, Straub L, Bernstein P, Atkinson MA, Herold KC, von Herrath M, Staeva T, Ehlers MR, et al. A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice. Diabetes. PMID 26718498 DOI: 10.2337/db15-0492  0.4
2015 Campbell-Thompson M, Fu A, Kaddis JS, Wasserfall C, Schatz DA, Pugliese A, Atkinson MA. Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes. Diabetes. PMID 26581594 DOI: 10.2337/db15-0779  0.4
2015 Haller MJ, Atkinson MA, Wasserfall CH, Brusko TM, Mathews CE, Hulme M, Cintron M, Shuster J, McGrail K, Posgai A, Schatz D. Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes. Clinical and Experimental Immunology. PMID 26462724 DOI: 10.1111/cei.12731  0.4
2015 Insel RA, Dunne JL, Atkinson MA, Chiang JL, Dabelea D, Gottlieb PA, Greenbaum CJ, Herold KC, Krischer JP, Lernmark Å, Ratner RE, Rewers MJ, Schatz DA, Skyler JS, Sosenko JM, et al. Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care. 38: 1964-74. PMID 26404926 DOI: 10.2337/dc15-1419  0.4
2015 Campbell-Thompson ML, Kaddis JS, Wasserfall C, Haller MJ, Pugliese A, Schatz DA, Shuster JJ, Atkinson MA. The influence of type 1 diabetes on pancreatic weight. Diabetologia. PMID 26358584 DOI: 10.1007/s00125-015-3752-z  0.4
2015 Yoon YM, Lewis JS, Carstens MR, Campbell-Thompson M, Wasserfall CH, Atkinson MA, Keselowsky BG. A combination hydrogel microparticle-based vaccine prevents type 1 diabetes in non-obese diabetic mice. Scientific Reports. 5: 13155. PMID 26279095 DOI: 10.1038/srep13155  0.4
2015 Li X, Atkinson MA. The role for gut permeability in the pathogenesis of type 1 diabetes--a solid or leaky concept? Pediatric Diabetes. 16: 485-92. PMID 26269193 DOI: 10.1111/pedi.12305  0.4
2015 Mathews CE, Xue S, Posgai A, Lightfoot YL, Li X, Lin A, Wasserfall C, Haller MJ, Schatz D, Atkinson MA. Acute Versus Progressive Onset of Diabetes in NOD Mice - Potential Implications for Therapeutic Interventions in Type 1 Diabetes. Diabetes. PMID 26216853 DOI: 10.2337/db15-0449  0.4
2015 Xue S, Posgai A, Wasserfall C, Myhr C, Campbell-Thompson M, Mathews CE, Brusko T, Rabinovitch A, Savinov A, Battaglia M, Schatz D, Haller M, Atkinson M. Combination therapy reverses hyperglycemia in NOD mice with established type 1 diabetes. Diabetes. PMID 26185279 DOI: 10.2337/db15-0164  0.4
2015 Atkinson MA, von Herrath M, Powers AC, Clare-Salzler M. Current concepts on the pathogenesis of type 1 diabetes--considerations for attempts to prevent and reverse the disease. Diabetes Care. 38: 979-88. PMID 25998290 DOI: 10.2337/dc15-0144  0.4
2015 Fuhrman CA, Yeh WI, Seay HR, Saikumar Lakshmi P, Chopra G, Zhang L, Perry DJ, McClymont SA, Yadav M, Lopez MC, Baker HV, Zhang Y, Li Y, Whitley M, von Schack D, ... Atkinson MA, et al. Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226. Journal of Immunology (Baltimore, Md. : 1950). 195: 145-55. PMID 25994968 DOI: 10.4049/jimmunol.1402381  0.4
2015 Lewis JS, Dolgova NV, Zhang Y, Xia CQ, Wasserfall CH, Atkinson MA, Clare-Salzler MJ, Keselowsky BG. A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice. Clinical Immunology (Orlando, Fla.). PMID 25842187 DOI: 10.1016/j.clim.2015.03.023  0.4
2015 Battaglia M, Atkinson MA. The streetlight effect in type 1 diabetes. Diabetes. 64: 1081-90. PMID 25805758 DOI: 10.2337/db14-1208  0.4
2015 Kemppainen KM, Ardissone AN, Davis-Richardson AG, Fagen JR, Gano KA, León-Novelo LG, Vehik K, Casella G, Simell O, Ziegler AG, Rewers MJ, Lernmark Å, Hagopian W, She JX, Krischer JP, ... ... Atkinson MA, et al. Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetes. Diabetes Care. 38: 329-32. PMID 25519450 DOI: 10.2337/dc14-0850  0.4
2015 Haller MJ, Gitelman SE, Gottlieb PA, Michels AW, Rosenthal SM, Shuster JJ, Zou B, Brusko TM, Hulme MA, Wasserfall CH, Mathews CE, Atkinson MA, Schatz DA. Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes. The Journal of Clinical Investigation. 125: 448-55. PMID 25500887 DOI: 10.1172/JCI78492  0.4
2014 Kushner JA, MacDonald PE, Atkinson MA. Stem cells to insulin secreting cells: two steps forward and now a time to pause? Cell Stem Cell. 15: 535-6. PMID 25517460 DOI: 10.1016/j.stem.2014.10.012  0.4
2014 Atkinson MA. Losing a grip on the notion of β-cell specificity for immune responses in type 1 diabetes: can we handle the truth? Diabetes. 63: 3572-4. PMID 25342726 DOI: 10.2337/db14-1069  0.4
2014 Xia CQ, Peng R, Chernatynskaya AV, Yuan L, Carter C, Valentine J, Sobel E, Atkinson MA, Clare-Salzler MJ. Increased IFN-α-producing plasmacytoid dendritic cells (pDCs) in human Th1-mediated type 1 diabetes: pDCs augment Th1 responses through IFN-α production. Journal of Immunology (Baltimore, Md. : 1950). 193: 1024-34. PMID 24973447 DOI: 10.4049/jimmunol.1303230  0.4
2014 Robert S, Gysemans C, Takiishi T, Korf H, Spagnuolo I, Sebastiani G, Van Huynegem K, Steidler L, Caluwaerts S, Demetter P, Wasserfall CH, Atkinson MA, Dotta F, Rottiers P, Van Belle TL, et al. Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. Diabetes. 63: 2876-87. PMID 24677716 DOI: 10.2337/db13-1236  0.4
2014 Dunne JL, Triplett EW, Gevers D, Xavier R, Insel R, Danska J, Atkinson MA. The intestinal microbiome in type 1 diabetes. Clinical and Experimental Immunology. 177: 30-7. PMID 24628412 DOI: 10.1111/cei.12321  0.4
2014 Atkinson MA. Pancreatic biopsies in type 1 diabetes: revisiting the myth of Pandora's box. Diabetologia. 57: 656-9. PMID 24442510 DOI: 10.1007/s00125-013-3159-7  0.4
2014 Pugliese A, Yang M, Kusmarteva I, Heiple T, Vendrame F, Wasserfall C, Rowe P, Moraski JM, Ball S, Jebson L, Schatz DA, Gianani R, Burke GW, Nierras C, Staeva T, ... ... Atkinson MA, et al. The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: Goals, operational model and emerging findings Pediatric Diabetes. 15: 1-9. PMID 24325575 DOI: 10.1111/pedi.12097  0.4
2014 Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet (London, England). 383: 69-82. PMID 23890997 DOI: 10.1016/S0140-6736(13)60591-7  0.4
2013 Atkinson MA, Ogle GD. Improving diabetes care in resource-poor countries: challenges and opportunities. The Lancet. Diabetes & Endocrinology. 1: 268-70. PMID 24622408 DOI: 10.1016/S2213-8587(13)70172-4  0.4
2013 Tian J, Dang H, Chen Z, Guan A, Jin Y, Atkinson MA, Kaufman DL. γ-Aminobutyric acid regulates both the survival and replication of human β-cells. Diabetes. 62: 3760-5. PMID 23995958 DOI: 10.2337/db13-0931  0.4
2013 Beran D, Yudkin JS, Atkinson MA. Global reality of type 1 diabetes care in 2013. Diabetes Care. 36: e144. PMID 23970723 DOI: 10.2337/dc13-0744  0.4
2013 Myhr CB, Hulme MA, Wasserfall CH, Hong PJ, Lakshmi PS, Schatz DA, Haller MJ, Brusko TM, Atkinson MA. The autoimmune disease-associated SNP rs917997 of IL18RAP controls IFNγ production by PBMC. Journal of Autoimmunity. 44: 8-12. PMID 23891168 DOI: 10.1016/j.jaut.2013.06.001  0.4
2013 Haller MJ, Wasserfall CH, Hulme MA, Cintron M, Brusko TM, McGrail KM, Wingard JR, Theriaque DW, Shuster JJ, Ferguson RJ, Kozuch M, Clare-Salzler M, Atkinson MA, Schatz DA. Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with Type 1 diabetes. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1126-9. PMID 23611977 DOI: 10.1016/j.bbmt.2013.04.011  0.4
2013 Atkinson MA. George S. Eisenbarth, 1947-2012 Diabetologia. 56: 435-438. PMID 23354126 DOI: 10.1007/s00125-013-2833-0  0.4
2013 Zhang Q, Fillmore TL, Schepmoes AA, Clauss TR, Gritsenko MA, Mueller PW, Rewers M, Atkinson MA, Smith RD, Metz TO. Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes. The Journal of Experimental Medicine. 210: 191-203. PMID 23277452 DOI: 10.1084/jem.20111843  0.4
2013 Staeva TP, Chatenoud L, Insel R, Atkinson MA. Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials. Diabetes. 62: 9-17. PMID 23258904 DOI: 10.2337/db12-0562  0.4
2013 Cabrera R, Ararat M, Xu Y, Brusko T, Wasserfall C, Atkinson MA, Chang LJ, Liu C, Nelson DR. Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma. Cancer Immunology, Immunotherapy : Cii. 62: 737-46. PMID 23223899 DOI: 10.1007/s00262-012-1380-8  0.4
2013 Atkinson MA. Trying to make a difference for those with Type 1 diabetes: A lesson in patience as well as a willingness to fail mightily Expert Review of Endocrinology and Metabolism. 8: 323-327. DOI: 10.1586/17446651.2013.811869  0.4
2013 Pugliese A, Campbell-Thompson M, Staeva T, Atkinson MA. The JDRF network for the pancreatic organ donor with diabetes (nPOD): A novel resource and study approach in type 1 diabetes research Diabetes and Viruses. 2147483647: 245-255. DOI: 10.1007/978-1-4614-4051-2_24  0.4
2012 Xia CQ, Chernatynskaya AV, Wasserfall CH, Wan S, Looney BM, Eisenbeis S, Williams J, Clare-Salzler MJ, Atkinson MA. Anti-thymocyte globulin (ATG) differentially depletes naïve and memory T cells and permits memory-type regulatory T cells in nonobese diabetic mice. Bmc Immunology. 13: 70. PMID 23237483 DOI: 10.1186/1471-2172-13-70  0.4
2012 Campbell-Thompson M, Wasserfall C, Montgomery EL, Atkinson MA, Kaddis JS. Pancreas organ weight in individuals with disease-associated autoantibodies at risk for type 1 diabetes. Jama. 308: 2337-9. PMID 23232891 DOI: 10.1001/jama.2012.15008  0.4
2012 Cabrera R, Fitian AI, Ararat M, Xu Y, Brusko T, Wasserfall C, Atkinson MA, Liu C, Nelson DR. Serum levels of soluble CD25 as a marker for hepatocellular carcinoma. Oncology Letters. 4: 840-846. PMID 23205111 DOI: 10.3892/ol.2012.826  0.4
2012 Atkinson MA. The pathogenesis and natural history of type 1 diabetes. Cold Spring Harbor Perspectives in Medicine. 2. PMID 23125199 DOI: 10.1101/cshperspect.a007641  0.4
2012 Atkinson MA, Chervonsky A. Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease Diabetologia. 55: 2868-2877. PMID 22875196 DOI: 10.1007/s00125-012-2672-4  0.4
2012 Gregg BE, Moore PC, Demozay D, Hall BA, Li M, Husain A, Wright AJ, Atkinson MA, Rhodes CJ. Formation of a human β-cell population within pancreatic islets is set early in life. The Journal of Clinical Endocrinology and Metabolism. 97: 3197-206. PMID 22745242 DOI: 10.1210/jc.2012-1206  0.4
2012 Campbell-Thompson ML, Montgomery EL, Foss RM, Kolheffer KM, Phipps G, Schneider L, Atkinson MA. Collection protocol for human pancreas. Journal of Visualized Experiments : Jove. e4039. PMID 22665046 DOI: 10.3791/4039  0.4
2012 Coppieters KT, Dotta F, Amirian N, Campbell PD, Kay TW, Atkinson MA, Roep BO, von Herrath MG. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. The Journal of Experimental Medicine. 209: 51-60. PMID 22213807 DOI: 10.1084/jem.20111187  0.4
2012 Hulme MA, Wasserfall CH, Atkinson MA, Brusko TM. Central role for interleukin-2 in type 1 diabetes. Diabetes. 61: 14-22. PMID 22187370 DOI: 10.2337/db11-1213  0.4
2011 Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N, Casella G, Drew JC, Ilonen J, Knip M, Hyöty H, Veijola R, Simell T, Simell O, Neu J, ... ... Atkinson MA, et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. Plos One. 6: e25792. PMID 22043294 DOI: 10.1371/journal.pone.0025792  0.4
2011 Michels AW, Ostrov DA, Zhang L, Nakayama M, Fuse M, McDaniel K, Roep BO, Gottlieb PA, Atkinson MA, Eisenbarth GS. Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation. Journal of Immunology (Baltimore, Md. : 1950). 187: 5921-30. PMID 22043012 DOI: 10.4049/jimmunol.1100746  0.4
2011 Schatz DA, Levine SR, Atkinson MA. It's time to mow the GRAS in type 1 diabetes. Diabetes. 60: 2669-71. PMID 22025772 DOI: 10.2337/db11-1158  0.4
2011 Haller MJ, Wasserfall CH, Hulme MA, Cintron M, Brusko TM, McGrail KM, Sumrall TM, Wingard JR, Theriaque DW, Shuster JJ, Atkinson MA, Schatz DA. Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptide. Diabetes Care. 34: 2567-9. PMID 22011412 DOI: 10.2337/dc11-1406  0.4
2011 Serreze DV, Chapman HD, Niens M, Dunn R, Kehry MR, Driver JP, Haller M, Wasserfall C, Atkinson MA. Loss of intra-islet CD20 expression may complicate efficacy of B-cell-directed type 1 diabetes therapies. Diabetes. 60: 2914-21. PMID 21926271 DOI: 10.2337/db11-0705  0.4
2011 Atkinson MA. Evaluating preclinical efficacy. Science Translational Medicine. 3: 96cm22. PMID 21849661 DOI: 10.1126/scitranslmed.3002757  0.4
2011 Wasserfall C, Nead K, Mathews C, Atkinson MA. The threshold hypothesis: Solving the equation of nurture vs nature in type 1 diabetes Diabetologia. 54: 2232-2236. PMID 21773685 DOI: 10.1007/s00125-011-2244-z  0.4
2011 Kelly-Scumpia KM, Scumpia PO, Weinstein JS, Delano MJ, Cuenca AG, Nacionales DC, Wynn JL, Lee PY, Kumagai Y, Efron PA, Akira S, Wasserfall C, Atkinson MA, Moldawer LL. B cells enhance early innate immune responses during bacterial sepsis. The Journal of Experimental Medicine. 208: 1673-82. PMID 21746813 DOI: 10.1084/jem.20101715  0.4
2011 Ize-Ludlow D, Lightfoot YL, Parker M, Xue S, Wasserfall C, Haller MJ, Schatz D, Becker DJ, Atkinson MA, Mathews CE. Progressive erosion of β-cell function precedes the onset of hyperglycemia in the NOD mouse model of type 1 diabetes. Diabetes. 60: 2086-91. PMID 21659497 DOI: 10.2337/db11-0373  0.4
2011 Atkinson MA, Bluestone JA, Eisenbarth GS, Hebrok M, Herold KC, Accili D, Pietropaolo M, Arvan PR, Von Herrath M, Markel DS, Rhodes CJ. How does type 1 diabetes develop?: the notion of homicide or β-cell suicide revisited. Diabetes. 60: 1370-9. PMID 21525508 DOI: 10.2337/db10-1797  0.4
2011 Yong J, Rasooly J, Dang H, Lu Y, Middleton B, Zhang Z, Hon L, Namavari M, Stout DB, Atkinson MA, Tian J, Gambhir SS, Kaufman DL. Multimodality imaging of β-cells in mouse models of type 1 and 2 diabetes. Diabetes. 60: 1383-92. PMID 21441442 DOI: 10.2337/db10-0907  0.4
2011 Greenbaum C, Atkinson MA. Persistence is the twin sister of excellence: an important lesson for attempts to prevent and reverse type 1 diabetes. Diabetes. 60: 693-4. PMID 21357468 DOI: 10.2337/db10-1810  0.4
2011 Grimstein C, Choi YK, Wasserfall CH, Satoh M, Atkinson MA, Brantly ML, Campbell-Thompson M, Song S. Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model. Journal of Translational Medicine. 9: 21. PMID 21345239 DOI: 10.1186/1479-5876-9-21  0.4
2011 Lau K, Benitez P, Ardissone A, Wilson TD, Collins EL, Lorca G, Li N, Sankar D, Wasserfall C, Neu J, Atkinson MA, Shatz D, Triplett EW, Larkin J. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. Journal of Immunology (Baltimore, Md. : 1950). 186: 3538-46. PMID 21317395 DOI: 10.4049/jimmunol.1001864  0.4
2011 Atkinson MA. It's time to consider changing the rules: the rationale for rethinking control groups in clinical trials aimed at reversing type 1 diabetes. Diabetes. 60: 361-3. PMID 21270247 DOI: 10.2337/db10-1506  0.4
2011 Giongo A, Gano KA, Crabb DB, Mukherjee N, Novelo LL, Casella G, Drew JC, Ilonen J, Knip M, Hyöty H, Veijola R, Simell T, Simell O, Neu J, Wasserfall CH, ... ... Atkinson MA, et al. Toward defining the autoimmune microbiome for type 1 diabetes. The Isme Journal. 5: 82-91. PMID 20613793 DOI: 10.1038/ismej.2010.92  0.4
2011 Rowe PA, Campbell-Thompson ML, Schatz DA, Atkinson MA. The pancreas in human type 1 diabetes. Seminars in Immunopathology. 33: 29-43. PMID 20495921 DOI: 10.1007/s00281-010-0208-x  0.4
2011 Atkinson MA. Response to comment on: Atkinson. It's time to consider changing the rules: The rationale for rethinking control groups in clinical trials aimed at reversing type 1 diabetes. Diabetes 2011;60:361-363 Diabetes. 60. DOI: 10.2337/db11-0365  0.4
2010 Cabrera R, Ararat M, Eksioglu EA, Cao M, Xu Y, Wasserfall C, Atkinson MA, Liu C, Nelson DR. Influence of serum and soluble CD25 (sCD25) on regulatory and effector T-cell function in hepatocellular carcinoma. Scandinavian Journal of Immunology. 72: 293-301. PMID 20883314 DOI: 10.1111/j.1365-3083.2010.02427.x  0.4
2010 Haller MJ, Atkinson MA, Schatz DA. Efforts to prevent and halt autoimmune beta cell destruction. Endocrinology and Metabolism Clinics of North America. 39: 527-39. PMID 20723818 DOI: 10.1016/j.ecl.2010.05.006  0.4
2010 Schatz DA, Haller MJ, Atkinson MA. Type I diabetes. Preface. Endocrinology and Metabolism Clinics of North America. 39: xvii-xviii. PMID 20723814 DOI: 10.1016/j.ecl.2010.05.012  0.4
2010 Li N, Hatch M, Wasserfall CH, Douglas-Escobar M, Atkinson MA, Schatz DA, Neu J. Butyrate and type 1 diabetes mellitus: can we fix the intestinal leak? Journal of Pediatric Gastroenterology and Nutrition. 51: 414-7. PMID 20706153 DOI: 10.1097/MPG.0b013e3181dd913a  0.4
2010 Brusko TM, Koya RC, Zhu S, Lee MR, Putnam AL, McClymont SA, Nishimura MI, Han S, Chang LJ, Atkinson MA, Ribas A, Bluestone JA. Human antigen-specific regulatory T cells generated by T cell receptor gene transfer. Plos One. 5: e11726. PMID 20668510 DOI: 10.1371/journal.pone.0011726  0.4
2010 Nierras CR, Atkinson MA, Goldstein RA. The juvenile diabetes research foundation at forty: Updates of research in type 1 diabetes Diabetes. 59: 1575-1577. PMID 20587801 DOI: 10.2337/db10-0622  0.4
2010 Valladares R, Sankar D, Li N, Williams E, Lai KK, Abdelgeliel AS, Gonzalez CF, Wasserfall CH, Larkin J, Schatz D, Atkinson MA, Triplett EW, Neu J, Lorca GL. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. Plos One. 5: e10507. PMID 20463897 DOI: 10.1371/journal.pone.0010507  0.4
2010 Cabrera R, Ararat M, Cao M, Xu Y, Wasserfall C, Atkinson MA, Liu C, Nelson DR. Hepatocellular carcinoma immunopathogenesis: clinical evidence for global T cell defects and an immunomodulatory role for soluble CD25 (sCD25). Digestive Diseases and Sciences. 55: 484-95. PMID 19714465 DOI: 10.1007/s10620-009-0955-5  0.4
2010 Xue S, Wasserfall C, Parker M, McGrail S, McGrail K, Campbell-Thompson M, Schatz DA, Atkinson MA, Haller MJ. Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area. Journal of Diabetes and Its Complications. 24: 163-7. PMID 19217320 DOI: 10.1016/j.jdiacomp.2008.12.004  0.4
2009 Brusko TM, Wasserfall CH, Hulme MA, Cabrera R, Schatz D, Atkinson MA. Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation. Plos One. 4: e7980. PMID 19956753 DOI: 10.1371/journal.pone.0007980  0.4
2009 Haller MJ, Wasserfall CH, McGrail KM, Cintron M, Brusko TM, Wingard JR, Kelly SS, Shuster JJ, Atkinson MA, Schatz DA. Autologous umbilical cord blood transfusion in very young children with type 1 diabetes. Diabetes Care. 32: 2041-6. PMID 19875605 DOI: 10.2337/dc09-0967  0.4
2009 Haller MJ, Atkinson MA, Schatz DA. The road not taken: a path to curing type 1 diabetes? European Journal of Immunology. 39: 2054-8. PMID 19672902 DOI: 10.1002/eji.200939517  0.4
2009 Parker MJ, Xue S, Alexander JJ, Wasserfall CH, Campbell-Thompson ML, Battaglia M, Gregori S, Mathews CE, Song S, Troutt M, Eisenbeis S, Williams J, Schatz DA, Haller MJ, Atkinson MA. Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice. Diabetes. 58: 2277-84. PMID 19628781 DOI: 10.2337/db09-0557  0.4
2009 Nayak S, Cao O, Hoffman BE, Cooper M, Zhou S, Atkinson MA, Herzog RW. Prophylactic immune tolerance induced by changing the ratio of antigen-specific effector to regulatory T cells Journal of Thrombosis and Haemostasis. 7: 1523-1532. PMID 19583824 DOI: 10.1111/j.1538-7836.2009.03548.x  0.4
2009 Atkinson MA, Gianani R. The pancreas in human type 1 diabetes: providing new answers to age-old questions. Current Opinion in Endocrinology, Diabetes, and Obesity. 16: 279-85. PMID 19502978 DOI: 10.1097/MED.0b013e32832e06ba  0.4
2009 Roesch LF, Casella G, Simell O, Krischer J, Wasserfall CH, Schatz D, Atkinson MA, Neu J, Triplett EW. Influence of fecal sample storage on bacterial community diversity. The Open Microbiology Journal. 3: 40-6. PMID 19440250 DOI: 10.2174/1874285800903010040  0.4
2009 Kosugi T, Heinig M, Nakayama T, Connor T, Yuzawa Y, Li Q, Hauswirth WW, Grant MB, Croker BP, Campbell-Thompson M, Zhang L, Atkinson MA, Segal MS, Nakagawa T. Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice. The American Journal of Pathology. 174: 1221-9. PMID 19246639 DOI: 10.2353/ajpath.2009.080605  0.4
2009 Roesch LF, Lorca GL, Casella G, Giongo A, Naranjo A, Pionzio AM, Li N, Mai V, Wasserfall CH, Schatz D, Atkinson MA, Neu J, Triplett EW. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. The Isme Journal. 3: 536-48. PMID 19225551 DOI: 10.1038/ismej.2009.5  0.4
2009 Wasserfall C, Atkinson MA. Taking a daily vitamin to prevent type 1 diabetes? Diabetes. 58: 24-5. PMID 19114727 DOI: 10.2337/db08-1479  0.4
2009 Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, Ghosh T, Atkinson MA, Bluestone JA. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes. 58: 652-62. PMID 19074986 DOI: 10.2337/db08-1168  0.4
2009 Pashuck TD, Franz SE, Altman MK, Wasserfall CH, Atkinson MA, Wronski TJ, Flotte TR, Stalvey MS. Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation. Pediatric Research. 65: 311-6. PMID 19047917 DOI: 10.1203/PDR.0b013e3181961e80  0.4
2009 Campbell-Thompson M, Dixon LR, Wasserfall C, Monroe M, McGuigan JM, Schatz D, Crawford JM, Atkinson MA. Pancreatic adenocarcinoma patients with localised chronic severe pancreatitis show an increased number of single beta cells, without alterations in fractional insulin area. Diabetologia. 52: 262-70. PMID 19002428 DOI: 10.1007/s00125-008-1200-z  0.4
2008 Xue S, Wasserfall CH, Parker M, Brusko TM, McGrail S, McGrail K, Moore M, Campbell-Thompson M, Schatz DA, Atkinson MA, Haller MJ. Exendin-4 therapy in NOD mice with new-onset diabetes increases regulatory T cell frequency. Annals of the New York Academy of Sciences. 1150: 152-6. PMID 19120286 DOI: 10.1196/annals.1447.049  0.4
2008 Yang P, Li M, Guo D, Gong F, Adam BL, Atkinson MA, Wang CY. Comparative analysis of the islet proteome between NOD/Lt and ALR/Lt mice. Annals of the New York Academy of Sciences. 1150: 68-71. PMID 19120270 DOI: 10.1196/annals.1447.002  0.4
2008 Sanjeevi CB, Schatz DA, Atkinson MA. The IDS conducts standardization of assays for the measurement of autoantibodies and of T cells in autoimmune diabetes. Preface. Annals of the New York Academy of Sciences. 1150: xiii. PMID 19120260 DOI: 10.1196/annals.1447.066  0.4
2008 Vaarala O, Atkinson MA, Neu J. The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes. 57: 2555-62. PMID 18820210 DOI: 10.2337/db08-0331  0.4
2008 Stalvey MS, Brusko TM, Mueller C, Wasserfall CH, Schatz DA, Atkinson MA, Flotte TR. CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes. Cytokine. 44: 154-9. PMID 18778952 DOI: 10.1016/j.cyto.2008.07.468  0.4
2008 George JF, Braun A, Brusko TM, Joseph R, Bolisetty S, Wasserfall CH, Atkinson MA, Agarwal A, Kapturczak MH. Suppression by CD4+CD25+ regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells. The American Journal of Pathology. 173: 154-60. PMID 18511516 DOI: 10.2353/ajpath.2008.070963  0.4
2008 Haller MJ, Viener HL, Wasserfall C, Brusko T, Atkinson MA, Schatz DA. Autologous umbilical cord blood infusion for type 1 diabetes. Experimental Hematology. 36: 710-5. PMID 18358588 DOI: 10.1016/j.exphem.2008.01.009  0.4
2008 King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M, Atkinson MA, Wasserfall C, Herold KC, Woodland RT, Schmidt MR, Woda BA, Thompson MJ, Rossini AA, Greiner DL. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clinical Immunology (Orlando, Fla.). 126: 303-14. PMID 18096436 DOI: 10.1016/j.clim.2007.11.001  0.4
2008 Caicedo RA, Li N, Des Robert C, Scumpia PO, Hubsher CP, Wasserfall CH, Schatz DA, Atkinson MA, Neu J. Neonatal formula feeding leads to immunological alterations in an animal model of type 1 diabetes. Pediatric Research. 63: 303-7. PMID 18091354 DOI: 10.1203/PDR.0b013e31815ed662  0.4
2008 Koya V, Lu S, Sun YP, Purich DL, Atkinson MA, Li SW, Yang LJ. Reversal of streptozotocin-induced diabetes in mice by cellular transduction with recombinant pancreatic transcription factor pancreatic duodenal homeobox-1: a novel protein transduction domain-based therapy. Diabetes. 57: 757-69. PMID 18086901 DOI: 10.2337/db07-1441  0.4
2007 Brusko TM, Hulme MA, Myhr CB, Haller MJ, Atkinson MA. Assessing the in vitro suppressive capacity of regulatory T cells. Immunological Investigations. 36: 607-28. PMID 18161521 DOI: 10.1080/08820130701790368  0.4
2007 Tsai YY, Oca-Cossio J, Agering K, Simpson NE, Atkinson MA, Wasserfall CH, Constantinidis I, Sigmund W. Novel synthesis of cerium oxide nanoparticles for free radical scavenging. Nanomedicine (London, England). 2: 325-32. PMID 17716177 DOI: 10.2217/17435889.2.3.325  0.4
2007 Scumpia PO, Delano MJ, Kelly-Scumpia KM, Weinstein JS, Wynn JL, Winfield RD, Xia C, Chung CS, Ayala A, Atkinson MA, Reeves WH, Clare-Salzler MJ, Moldawer LL. Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood. 110: 3673-81. PMID 17690255 DOI: 10.1182/blood-2007-04-087171  0.4
2007 Montoya CJ, Pollard D, Martinson J, Kumari K, Wasserfall C, Mulder CB, Rugeles MT, Atkinson MA, Landay AL, Wilson SB. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology. 122: 1-14. PMID 17662044 DOI: 10.1111/j.1365-2567.2007.02647.x  0.4
2007 Delano MJ, Scumpia PO, Weinstein JS, Coco D, Nagaraj S, Kelly-Scumpia KM, O'Malley KA, Wynn JL, Antonenko S, Al-Quran SZ, Swan R, Chung CS, Atkinson MA, Ramphal R, Gabrilovich DI, et al. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. The Journal of Experimental Medicine. 204: 1463-74. PMID 17548519 DOI: 10.1084/jem.20062602  0.4
2007 Zheng Y, Kreuwel HT, Young DL, Shoda LK, Ramanujan S, Gadkar KG, Atkinson MA, Whiting CC. The virtual NOD mouse: applying predictive biosimulation to research in type 1 diabetes. Annals of the New York Academy of Sciences. 1103: 45-62. PMID 17376834 DOI: 10.1196/annals.1394.014  0.4
2007 Schwartz RF, Neu J, Schatz D, Atkinson MA, Wasserfall C. Comment on: Brugman S et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49:2105-2108 [4] Diabetologia. 50: 220-221. PMID 17119915 DOI: 10.1007/s00125-006-0526-7  0.4
2006 Scumpia PO, Delano MJ, Kelly KM, O'Malley KA, Efron PA, McAuliffe PF, Brusko T, Ungaro R, Barker T, Wynn JL, Atkinson MA, Reeves WH, Salzler MJ, Moldawer LL. Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. Journal of Immunology (Baltimore, Md. : 1950). 177: 7943-9. PMID 17114466  0.4
2006 Lu Y, Dang H, Middleton B, Campbell-Thompson M, Atkinson MA, Sam Gambhir S, Tian J, Kaufman DL. Long-Term Monitoring of Transplanted Islets Using Positron Emission Tomography Molecular Therapy. 14: 851-856. PMID 16982215 DOI: 10.1016/j.ymthe.2006.08.007  0.4
2006 Wasserfall CH, Atkinson MA. Autoantibody markers for the diagnosis and prediction of type 1 diabetes Autoimmunity Reviews. 5: 424-428. PMID 16890898 DOI: 10.1016/j.autrev.2005.12.002  0.4
2006 Stalvey MS, Muller C, Schatz DA, Wasserfall CH, Campbell-Thompson ML, Theriaque DW, Flotte TR, Atkinson MA. Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury. Diabetes. 55: 1939-45. PMID 16804061 DOI: 10.2337/db05-1647  0.4
2006 Burkhardt BR, Greene SR, White P, Wong RK, Brestelli JE, Yang J, Robert CE, Brusko TM, Wasserfall CH, Wu J, Atkinson MA, Gao Z, Kaestner KH, Wolf BA. PANDER-induced cell-death genetic networks in islets reveal central role for caspase-3 and cyclin-dependent kinase inhibitor 1A (p21). Gene. 369: 134-41. PMID 16412588 DOI: 10.1016/j.gene.2005.10.040  0.4
2006 Burkhardt BR, Lyle R, Qian K, Arnold AS, Cheng H, Atkinson MA, Zhang YC. Efficient delivery of siRNA into cytokine-stimulated insulinoma cells silences Fas expression and inhibits Fas-mediated apoptosis. Febs Letters. 580: 553-60. PMID 16412430 DOI: 10.1016/j.febslet.2005.12.068  0.4
2005 Schatz DA, Atkinson MA. Islet cell autoantibodies: A case of a premature obituary Pediatric Diabetes. 6: 181-183. PMID 16390385 DOI: 10.1111/j.1399-543X.2005.00128.x  0.4
2005 Haller MJ, Atkinson MA, Schatz D. Type 1 diabetes mellitus: Etiology, presentation, and management Pediatric Clinics of North America. 52: 1553-1578. PMID 16301083 DOI: 10.1016/j.pcl.2005.07.006  0.4
2005 Burkhardt BR, Parker MJ, Zhang YC, Song S, Wasserfall CH, Atkinson MA. Glucose transporter-2 (GLUT2) promoter mediated transgenic insulin production reduces hyperglycemia in diabetic mice. Febs Letters. 579: 5759-64. PMID 16223491 DOI: 10.1016/j.febslet.2005.09.060  0.4
2005 Atkinson MA, Rhodes CJ. Pancreatic regeneration in type 1 diabetes: Dreams on a deserted islet? Diabetologia. 48: 2200-2202. PMID 16193285 DOI: 10.1007/s00125-005-1957-2  0.4
2005 Lee CH, Reifsnyder PC, Naggert JK, Wasserfall C, Atkinson MA, Chen J, Leiter EH. Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: I. Pathophysiological analysis Diabetes. 54: 2525-2532. PMID 16123339 DOI: 10.2337/diabetes.54.9.2525  0.4
2005 Brusko TM, Wasserfall CH, Clare-Salzler MJ, Schatz DA, Atkinson MA. Functional defects and the influence of age on the frequency of CD4 +CD25+ T-cells in type 1 diabetes Diabetes. 54: 1407-1414. PMID 15855327 DOI: 10.2337/diabetes.54.5.1407  0.4
2005 Atkinson MA. Thirty years of investigating the autoimmune basis for type 1 diabetes: Why can't we prevent or reverse this disease? Diabetes. 54: 1253-1263. PMID 15855308 DOI: 10.2337/diabetes.54.5.1253  0.4
2005 Brusko TM, Wasserfall CH, Agarwal A, Kapturczak MH, Atkinson MA. An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cells. Journal of Immunology (Baltimore, Md. : 1950). 174: 5181-6. PMID 15843512  0.4
2004 Kapturczak MH, Wasserfall C, Brusko T, Campbell-Thompson M, Ellis TM, Atkinson MA, Agarwal A. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. The American Journal of Pathology. 165: 1045-53. PMID 15331427 DOI: 10.1016/S0002-9440(10)63365-2  0.4
2004 Tang DQ, Cao LZ, Burkhardt BR, Xia CQ, Litherland SA, Atkinson MA, Yang LJ. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow Diabetes. 53: 1721-1732. PMID 15220196 DOI: 10.2337/diabetes.53.7.1721  0.4
2004 Zhang YC, Atkinson MA. Gene therapy for type 1 diabetes: Metabolism, immunity, islet cell preservation, and regeneration Current Opinion in Endocrinology and Diabetes. 11: 91-97.  0.4
2003 Schatz D, Gale EAM, Atkinson MA. Why Can't We Prevent Type I Diabetes?: Maybe it's time to try a different combination Diabetes Care. 26: 3326-3328. PMID 14633822 DOI: 10.2337/diacare.26.12.3326  0.4
2003 Qin HY, Mahon JL, Atkinson MA, Chaturvedi P, Lee-Chan E, Singh B. Type 1 diabetes alters anti-hsp90 autoantibody isotype Journal of Autoimmunity. 20: 237-245. PMID 12753809 DOI: 10.1016/S0896-8411(03)00035-0  0.4
2002 Atkinson MA, Wilson SB. Fatal attraction: chemokines and type 1 diabetes. The Journal of Clinical Investigation. 110: 1611-3. PMID 12464665 DOI: 10.1172/JCI17311  0.4
2001 Kapturczak MH, Flotte T, Atkinson MA. Adeno-Associated Virus (AAV) as a vehicle for therapeutic gene delivery: Improvements in vector design and viral production enhance potential to prolong graft survival in pancreatic islet cell transplantation for the reversal of type 1 diabetes Current Molecular Medicine. 1: 245-258. PMID 11899074  0.4
2001 Atkinson MA, Eisenbarth GS. Type 1 diabetes: New perspectives on disease pathogenesis and treatment Lancet. 358: 221-229. PMID 11476858 DOI: 10.1016/S0140-6736(01)05415-0  0.4
2001 Peakman M, Tree TI, Endl J, Van Endert P, Atkinson MA, Roep BO. Characterization of Preparations of GAD65, Proinsulin, and the Islet Tyrosine Phosphatase IA-2 for Use in Detection of Autoreactive T-Cells in Type 1 Diabetes: Report of Phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell Assays in Type 1 Diabetes Diabetes. 50: 1749-1754. PMID 11473034  0.4
2001 Tisch R, Wang B, Atkinson MA, Serreze DV, Friedline R. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice Journal of Immunology. 166: 6925-6936. PMID 11359854  0.4
2001 Bingley PJ, Bonifacio E, Ziegler AG, Schatz DA, Atkinson MA, Eisenbarth GS. Proposed guidelines on screening for risk of type 1 diabetes Diabetes Care. 24: 398. PMID 11213898  0.4
2000 Serreze DV, Ottendorfer EW, Elliss TM, Gauntt CJ, Atkinson MA. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets Diabetes. 49: 708-711. PMID 10905477  0.4
2000 Atkinson MA. The $64,000 question in diabetes continues . . Lancet. 355: 4-6. PMID 10892753  0.4
2000 Falta MT, Atkinson MA, Allegretta M, Vacek PM, Albertini RJ. Azathioprine associated T-cell mutations in insulin-dependent diabetes mellitus Scandinavian Journal of Immunology. 51: 626-633. PMID 10849375 DOI: 10.1046/j.1365-3083.2000.00742.x  0.4
1999 Ottendorfer E, Ellis TM, Bahjat KS, Clare-Salzler M, Atkinson MA. No alteration in T lymphocyte expression of CD40 ligand (CD154) in individuals with or at increased risk for insulin-dependent diabetes mellitus Journal of Clinical Endocrinology and Metabolism. 84: 4068-4072. PMID 10566651  0.4
1999 Roep BO, Atkinson MA, van Endert PM, Gottlieb PA, Wilson SB, Sachs JA. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays. Journal of Autoimmunity. 13: 267-82. PMID 10479395 DOI: 10.1006/jaut.1999.0312  0.4
1999 Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: As good as it gets? Nature Medicine. 5: 601-604. PMID 10371488 DOI: 10.1038/9442  0.4
1999 Ellis T, Jodoin E, Ottendorfer E, Salisbury P, She JX, Schatz D, Atkinson MA. Cellular immune responses against proinsulin: No evidence for enhanced reactivity in individuals with IDDM Diabetes. 48: 299-303. PMID 10334305 DOI: 10.2337/diabetes.48.2.299  0.4
1999 Falta MT, Magin GK, Allegretta M, Steinman L, Atkinson MA, Brostoff SW, Albertini RJ. Selection of hprt mutant T cells as surrogates for dividing cells reveals a restricted T cell receptor BV repertoire in insulin-dependent diabetes mellitus Clinical Immunology. 90: 340-351. PMID 10075863 DOI: 10.1006/clim.1998.4664  0.4
1999 Leslie RD, Atkinson MA, Notkins AL. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes. Diabetologia. 42: 3-14. PMID 10027571 DOI: 10.1007/s001250051105  0.4
1998 Ellis TM, Ottendorfer E, Jodoin E, Salisbury PJ, She JX, Schatz DA, Atkinson MA. Cellular immune responses to β casein: Elevated in but not specific for individuals with Type I diabetes mellitus Diabetologia. 41: 731-735. PMID 9662058 DOI: 10.1007/s001250050976  0.4
1998 Zechel MA, Elliott JF, Atkinson MA, Singh B. Characterization of novel T-cell epitopes on 65 kDa and 67 kDa glutamic acid decarboxylase relevant in autoimmune responses in NOD mice Journal of Autoimmunity. 11: 83-95. PMID 9480726 DOI: 10.1006/jaut.1997.0178  0.4
1997 Atkinson MA. Molecular mimicry and the pathogenesis of insulin-dependent diabetes mellitus: Still just an attractive hypothesis Annals of Medicine. 29: 393-399. PMID 9453286  0.4
1997 Cetkovic-Cvrlje M, Gerling IC, Muir A, Atkinson MA, Elliott JF, Leiter EH. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate β-cell antigens Diabetes. 46: 1975-1982. PMID 9392483  0.4
1997 Atkinson MA. Mechanisms underlying the loss of serf tolerance in NOD mice Research in Immunology. 148: 301-306. PMID 9352593 DOI: 10.1016/S0923-2494(97)87238-0  0.4
1997 Ellis TM, Hardt NS, Campbell L, Piacentini DA, Atkinson MA. Cellular immune reactivities in women with silicone breast implants: A preliminary investigation Annals of Allergy, Asthma and Immunology. 79: 151-154. PMID 9291420  0.4
1997 Atkinson MA, Ellis TM. Infants diets and insulin-dependent diabetes: Evaluating the 'cows' milk hypothesis' and a role for anti-bovine serum albumin immunity Journal of the American College of Nutrition. 16: 334-340. PMID 9263182  0.4
1997 Ellis TM, Hardt NS, Atkinson MA. Antipolymer antibodies, silicone breast implants, and fibromyalgia Lancet. 349: 1173. PMID 9113032  0.4
1997 Atkinson MA. Diet, genetics, and diabetes Food Technology. 51.  0.4
1996 Bowman MA, Simell OG, Peck AB, Cornelius J, Luchetta R, Look Z, Maclaren NK, Atkinson MA. Pharmacokinetics of aminoguanidine administration and effects on the diabetes frequency in nonobese diabetic mice Journal of Pharmacology and Experimental Therapeutics. 279: 790-794. PMID 8930185  0.4
1996 Ellis TM, Atkinson MA. Early infant diets and insulin-dependent diabetes Lancet. 347: 1464-1465. PMID 8676633 DOI: 10.1016/S0140-6736(96)91690-6  0.4
1996 Tian J, Atkinson MA, Clare-Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV, Kaufman DL. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes Journal of Experimental Medicine. 183: 1561-1567. PMID 8666914 DOI: 10.1084/jem.183.4.1561  0.4
1996 Ellis TM, Atkinson MA. The clinical significance of an autoimmune response against glutamic acid decarboxylase Nature Medicine. 2: 148-153. PMID 8574952 DOI: 10.1038/nm0296-148  0.4
1996 Bowman MA, Campbell L, Darrow BL, Ellis TM, Suresh A, Atkinson MA. Immunological and metabolic effects of prophylactic insulin therapy in the NOD-scid/scid adoptive transfer model of IDDM. Diabetes. 45: 205-8. PMID 8549866  0.4
1995 Huang L, Shen H, Atkinson MA, Kennedy RT. Detection of exocytosis at individual pancreatic beta cells by amperometry at a chemically modified microelectrode. Proceedings of the National Academy of Sciences of the United States of America. 92: 9608-12. PMID 7568182 DOI: 10.1073/pnas.92.21.9608  0.4
1994 Dosch HM, Karjalainen J, VanderMeulen J, Atkinson MA, Kao KJ, Maclaren NK. Lack of immunity to bovine serum albumin in insulin-dependent diabetes mellitus [3] New England Journal of Medicine. 330: 1616-1617. PMID 8177260 DOI: 10.1056/NEJM199406023302216  0.4
1994 Atkinson MA, Maclaren NK. Mechanisms of disease: The pathogenesis of insulin-dependent diabetes mellitus New England Journal of Medicine. 331: 1428-1436. PMID 7969282 DOI: 10.1056/NEJM199411243312107  0.4
1994 Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. The Journal of Clinical Investigation. 94: 2125-9. PMID 7962558 DOI: 10.1172/JCI117567  0.4
1994 Gerling IC, Atkinson MA, Leiter EH. The thymus as a site for evaluating the potency of candidate β cell autoantigens in NOD mice Journal of Autoimmunity. 7: 851-858. PMID 7888041 DOI: 10.1006/jaut.1994.1068  0.4
1994 Bowman MA, Leiter EH, Atkinson MA. Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease Trends in Immunology. 15: 115-120. DOI: 10.1016/0167-5699(94)90154-6  0.4
1993 Atkinson MA, Kaufman DL, Newman D, Tobin AJ, Maclaren NK. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. The Journal of Clinical Investigation. 91: 350-6. PMID 8423231 DOI: 10.1172/JCI116192  0.4
1993 Atkinson MA, Maclaren NK. Islet cell autoantigens in insulin-dependent diabetes Journal of Clinical Investigation. 92: 1608-1616. PMID 8408615  0.4
1993 Kennedy RT, Huang L, Atkinson MA, Dush P. Amperometric monitoring of chemical secretions from individual pancreatic beta-cells. Analytical Chemistry. 65: 1882-7. PMID 8368536  0.4
1992 Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. The Journal of Clinical Investigation. 89: 283-92. PMID 1370298 DOI: 10.1172/JCI115573  0.4
1992 Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu DF, Erlander MG, Tobin AJ, Maclaren NK. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet. 339: 458-9. PMID 1346821 DOI: 10.1016/0140-6736(92)91061-C  0.4
1991 Atkinson MA, Holmes LA, Scharp DW, Lacy PE, Maclaren NK. No evidence for serological autoimmunity to islet cell heat shock proteins in insulin dependent diabetes Journal of Clinical Investigation. 87: 721-724. PMID 1991854  0.4
1990 Atkinson MA, Maclaren NK. What causes diabetes? Scientific American. 263: 62-71. PMID 2197720  0.4
1990 Atkinson MA, Maclaren NK, Luchetta R. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy Diabetes. 39: 933-937. PMID 2197139  0.4
1990 Riley WJ, Atkinson MA, Schatz DA, Maclaren NK. Comparison of islet autoantibodies in 'pre-diabetes' and recommendations for screening Journal of Autoimmunity. 3: 47-51. PMID 2187460  0.4
1990 Atkinson MA, Maclaren NK, Holmes L, Scharp DW, Lacy PE, Riley WJ. The natural history and predictive value of M(r) 64,000 autoantibodies for insulin-dependent diabetes mellitus Journal of Autoimmunity. 3: 41-45. PMID 2187459  0.4
1990 Atkinson MA, Maclaren NK, Riley WJ, Sharp DW, Lacey PE. 64 000 Mr autoantibodies as predictors of insulin-dependent diabetes The Lancet. 335: 1357-1360. PMID 1971659 DOI: 10.1016/0140-6736(90)91241-2  0.4
1988 Atkinson MA, Winter WE, Skordis N, Beppu H, Riley WM, Maclaren NK. Dietary protein restriction reduces the frequency and delays the onset of insulin dependent diabetes in BB rats Autoimmunity. 2: 11-19. PMID 3155150 DOI: 10.3109/08916938809019939  0.4
1988 Riley WJ, Atkinson MA, MacLaren NK. Insulin autoantibodies in pre-diabetes Advances in Experimental Medicine and Biology. 246: 45-51. PMID 3074667  0.4
1988 Atkinson MA, Maclaren NK. Autoantibodies in nonobese diabetic mice immunoprecipitate 64,000-M(r) islet antigen Diabetes. 37: 1587-1590. PMID 3053305  0.4
1987 Beppu H, Winter WE, Atkinson MA, Maclaren NK, Fujita K, Takahashi H. Bovine albumin antibodies in NOD mice Diabetes Research. 6: 67-69. PMID 3427869  0.4
1986 Atkinson MA, Maclaren NK, Riley WJ, Winter WE, Fisk DD, Spillar RP. Are insulin autoantibodies markers for insulin-dependent diabetes mellitus? Diabetes. 35: 894-898. PMID 3525287  0.4
Show low-probability matches.